2006 blev et meget tilfredsstillende år for Novozymes. Vækst på 11% i indtjeningen, 8% i salget og frie pengestrømme på 1.058 mio. kr. levede til fulde op til forventningerne. Væksten forventes at fortsætte i 2007.
Attachments
Recommended Reading
-
COPENHAGEN, Denmark, August 12, 2026 – Novonesis today announced the launch of Optiva® Triticum, a new biosolution that helps pasta manufacturers increase flexibility in wheat sourcing while...
Read More -
Novonesis to acquire remaining share of MicroBioGen to strengthen yeast capabilities COPENHAGEN, Denmark, August 10 – Novonesis has signed an agreement with the intent to acquire MicroBioGen, an...
Read More